Similar articles for PMID: 31394623

Year	Number of Results
1998	1
2001	2
2003	1
2004	2
2005	5
2006	7
2007	4
2008	9
2009	6
2010	2
2011	6
2012	5
2013	1
2014	3
2015	8
2016	4
2017	2
2018	1
2024	0

1

Application of Microarrays for the Prediction of Therapy Response in Breast Cancer.

Györffy B, Surowiak P, Lage H. Györffy B, et al. Cancer Genomics Proteomics. 2005 Sep-Oct;2(5):255-263. Epub 2005 Sep 1. Cancer Genomics Proteomics. 2005. PMID: 31394623 Free article. Review.

2

Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A. Rody A, et al. Zentralbl Gynakol. 2006 Apr;128(2):76-81. doi: 10.1055/s-2006-921508. Zentralbl Gynakol. 2006. PMID: 16673249 Clinical Trial.

3

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Gonzalez-Angulo AM, et al. Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.

4

Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.

Lehmann BD, Ding Y, Viox DJ, Jiang M, Zheng Y, Liao W, Chen X, Xiang W, Yi Y. Lehmann BD, et al. BMC Cancer. 2015 Mar 26;15:179. doi: 10.1186/s12885-015-1102-7. BMC Cancer. 2015. PMID: 25886164 Free PMC article.

5

Multigene prognostic tests in breast cancer: past, present, future.

Győrffy B, Hatzis C, Sanft T, Hofstatter E, Aktas B, Pusztai L. Győrffy B, et al. Breast Cancer Res. 2015 Jan 27;17(1):11. doi: 10.1186/s13058-015-0514-2. Breast Cancer Res. 2015. PMID: 25848861 Free PMC article. Review.

6

[Gene expression profiling of ER+ breast cancers: to discriminate the poor prognosis tumors or to define the most suitable treatment?].

Chanrion M, Darbon JM. Chanrion M, et al. Bull Cancer. 2008 May;95(5):513-8. doi: 10.1684/bdc.2008.0646. Bull Cancer. 2008. PMID: 18541515 Free article. Review. French.

7

Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.

Lancashire LJ, Rees RC, Ball GR. Lancashire LJ, et al. Artif Intell Med. 2008 Jun;43(2):99-111. doi: 10.1016/j.artmed.2008.03.001. Epub 2008 Apr 16. Artif Intell Med. 2008. PMID: 18420392

8

DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy.

Hartmann O, Spyratos F, Harbeck N, Dietrich D, Fassbender A, Schmitt M, Eppenberger-Castori S, Vuaroqueaux V, Lerebours F, Welzel K, Maier S, Plum A, Niemann S, Foekens JA, Lesche R, Martens JW. Hartmann O, et al. Clin Cancer Res. 2009 Jan 1;15(1):315-23. doi: 10.1158/1078-0432.CCR-08-0166. Clin Cancer Res. 2009. PMID: 19118060 Clinical Trial.

9

National Oncology Forum: perspectives for the year 2000.

DeVita VT Jr, Bleickardt EW. DeVita VT Jr, et al. Cancer J. 2001 Jul-Aug;7 Suppl 1:S2-13. Cancer J. 2001. PMID: 11504281 Review.

10

Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.

Iwamoto T, Kelly C, Mizoo T, Nogami T, Motoki T, Shien T, Taira N, Hayashi N, Niikura N, Fujiwara T, Doihara H, Matsuoka J. Iwamoto T, et al. Clin Breast Cancer. 2016 Apr;16(2):95-100.e1. doi: 10.1016/j.clbc.2015.10.004. Epub 2015 Nov 10. Clin Breast Cancer. 2016. PMID: 26631838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year